메뉴 건너뛰기




Volumn 12, Issue 1, 2013, Pages

Asymmetric dimethylarginine predicts decline of glucose tolerance in men with stable coronary artery disease: A 4.5-year follow-up study

Author keywords

ADMA; Coronary artery disease; Insulin resistance; New onset type 2 diabetes; Pre diabetes

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; N(G),N(G) DIMETHYLARGININE; TRIACYLGLYCEROL; ARGININE; N,N-DIMETHYLARGININE;

EID: 84875959197     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-12-64     Document Type: Article
Times cited : (20)

References (60)
  • 1
    • 0001654669 scopus 로고    scopus 로고
    • Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction
    • 10.1161/01.CIR.101.9.948, 10704159
    • Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000, 101:948-954. 10.1161/01.CIR.101.9.948, 10704159.
    • (2000) Circulation , vol.101 , pp. 948-954
    • Suwaidi, J.A.1    Hamasaki, S.2    Higano, S.T.3    Nishimura, R.A.4    Holmes, D.R.5    Lerman, A.6
  • 2
    • 2142649221 scopus 로고    scopus 로고
    • Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus
    • 10.1001/jama.291.16.1978, 15113816
    • Meigs JB, Hu FB, Rifai N, Manson JE. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 2004, 291:1978-1986. 10.1001/jama.291.16.1978, 15113816.
    • (2004) JAMA , vol.291 , pp. 1978-1986
    • Meigs, J.B.1    Hu, F.B.2    Rifai, N.3    Manson, J.E.4
  • 3
    • 33644859602 scopus 로고    scopus 로고
    • Elevated markers of endothelial dysfunction predict type 2 diabetes mellitus in middle-aged men and women from the general population
    • MONICA/KORA Study Group
    • Thorand B, Baumert J, Chambless L, Meisinger C, Kolb H, Döring A, Löwel H, Koenig W, . MONICA/KORA Study Group Elevated markers of endothelial dysfunction predict type 2 diabetes mellitus in middle-aged men and women from the general population. Arterioscler Thromb Vasc Biol 2006, 26:398-405. MONICA/KORA Study Group.
    • (2006) Arterioscler Thromb Vasc Biol , vol.26 , pp. 398-405
    • Thorand, B.1    Baumert, J.2    Chambless, L.3    Meisinger, C.4    Kolb, H.5    Döring, A.6    Löwel, H.7    Koenig, W.8
  • 4
    • 33845955836 scopus 로고    scopus 로고
    • Circulating oxidised low-density lipoprotein and intercellular adhesion molecule-1 and risk of type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study
    • Hoogeveen RC, Ballantyne CM, Bang H, Heiss G, Duncan BB, Folsom AR, Pankow JS. Circulating oxidised low-density lipoprotein and intercellular adhesion molecule-1 and risk of type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Diabetologia 2007, 50:36-42.
    • (2007) Diabetologia , vol.50 , pp. 36-42
    • Hoogeveen, R.C.1    Ballantyne, C.M.2    Bang, H.3    Heiss, G.4    Duncan, B.B.5    Folsom, A.R.6    Pankow, J.S.7
  • 6
    • 0027762766 scopus 로고
    • Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians
    • 10.1056/NEJM199312303292703, 8247074
    • Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 1993, 329:1988-1992. 10.1056/NEJM199312303292703, 8247074.
    • (1993) N Engl J Med , vol.329 , pp. 1988-1992
    • Lillioja, S.1    Mott, D.M.2    Spraul, M.3    Ferraro, R.4    Foley, J.E.5    Ravussin, E.6    Knowler, W.C.7    Bennett, P.H.8    Bogardus, C.9
  • 7
    • 0035132672 scopus 로고    scopus 로고
    • Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development
    • 10.2337/diacare.24.1.89, 11194248
    • Weyer C, Tataranni PA, Bogardus C, Pratley RE. Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diabetes Care 2001, 24:89-94. 10.2337/diacare.24.1.89, 11194248.
    • (2001) Diabetes Care , vol.24 , pp. 89-94
    • Weyer, C.1    Tataranni, P.A.2    Bogardus, C.3    Pratley, R.E.4
  • 8
    • 0037315294 scopus 로고    scopus 로고
    • Insulin Resistance Atherosclerosis Study: Prediction of type 2 diabetes using simple measures of insulin resistance: combined results from the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study.
    • San Antonio Heart Study; Mexico City Diabetes Study
    • Hanley AJ, Williams K, Gonzalez C, D'Agostino RB, Wagenknecht LE, Stern MP, Haffner SM, . San Antonio Heart Study; Mexico City Diabetes Study Insulin Resistance Atherosclerosis Study: Prediction of type 2 diabetes using simple measures of insulin resistance: combined results from the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study. Diabetes 2003, 52:463-469. San Antonio Heart Study; Mexico City Diabetes Study.
    • (2003) Diabetes , vol.52 , pp. 463-469
    • Hanley, A.J.1    Williams, K.2    Gonzalez, C.3    D'Agostino, R.B.4    Wagenknecht, L.E.5    Stern, M.P.6    Haffner, S.M.7
  • 9
    • 80052547130 scopus 로고    scopus 로고
    • Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study
    • 10.1007/s00125-011-2112-x, 21424899, RISC Investigators
    • Ferrannini E, Natali A, Muscelli E, Nilsson PM, Golay A, Laakso M, Beck-Nielsen H, Mari A, . RISC Investigators Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study. Diabetologia 2011, 54:1507-1516. 10.1007/s00125-011-2112-x, 21424899, RISC Investigators.
    • (2011) Diabetologia , vol.54 , pp. 1507-1516
    • Ferrannini, E.1    Natali, A.2    Muscelli, E.3    Nilsson, P.M.4    Golay, A.5    Laakso, M.6    Beck-Nielsen, H.7    Mari, A.8
  • 11
    • 84862250271 scopus 로고    scopus 로고
    • Insulin resistance predicts progression of de novo atherosclerotic plaques in patients with coronary heart disease: a one-year follow-up study
    • 10.1186/1475-2840-11-71, 3441242, 22709409
    • An X, Yu D, Zhang R, Zhu J, Du R, Shi Y, Xiong X. Insulin resistance predicts progression of de novo atherosclerotic plaques in patients with coronary heart disease: a one-year follow-up study. Cardiovasc Diabetol 2012, 11:71. 10.1186/1475-2840-11-71, 3441242, 22709409.
    • (2012) Cardiovasc Diabetol , vol.11 , pp. 71
    • An, X.1    Yu, D.2    Zhang, R.3    Zhu, J.4    Du, R.5    Shi, Y.6    Xiong, X.7
  • 12
    • 70350057304 scopus 로고    scopus 로고
    • Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality-An update on patient populations with a wide range of cardiovascular risk
    • 10.1016/j.phrs.2009.07.001, 19596069
    • Böger RH, Maas R, Schulze F, Schwedhelm E. Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality-An update on patient populations with a wide range of cardiovascular risk. Pharmacol Res 2009, 60:481-487. 10.1016/j.phrs.2009.07.001, 19596069.
    • (2009) Pharmacol Res , vol.60 , pp. 481-487
    • Böger, R.H.1    Maas, R.2    Schulze, F.3    Schwedhelm, E.4
  • 13
    • 33947514236 scopus 로고    scopus 로고
    • Elevated concentrations of asymmetric dimethylarginine are associated with deterioration of glucose tolerance in women with previous gestational diabetes mellitus
    • 10.1111/j.1365-2796.2007.01772.x, 17391114
    • Mittermayer F, Kautzky-Willer A, Winzer C, Krzyżanowska K, Prikoszovich T, Demehri S, Wagner O, Wolzt M. Elevated concentrations of asymmetric dimethylarginine are associated with deterioration of glucose tolerance in women with previous gestational diabetes mellitus. J Intern Med 2007, 261:392-398. 10.1111/j.1365-2796.2007.01772.x, 17391114.
    • (2007) J Intern Med , vol.261 , pp. 392-398
    • Mittermayer, F.1    Kautzky-Willer, A.2    Winzer, C.3    Krzyzanowska, K.4    Prikoszovich, T.5    Demehri, S.6    Wagner, O.7    Wolzt, M.8
  • 15
    • 0037139438 scopus 로고    scopus 로고
    • Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor
    • 10.1001/jama.287.11.1420, 11903029
    • Stühlinger MC, Abbasi F, Chu JW, Lamendola C, McLaughlin TL, Cooke JP, Reaven GM, Tsao PS. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA 2002, 287:1420-1426. 10.1001/jama.287.11.1420, 11903029.
    • (2002) JAMA , vol.287 , pp. 1420-1426
    • Stühlinger, M.C.1    Abbasi, F.2    Chu, J.W.3    Lamendola, C.4    McLaughlin, T.L.5    Cooke, J.P.6    Reaven, G.M.7    Tsao, P.S.8
  • 16
    • 33646420076 scopus 로고    scopus 로고
    • Plasma asymmetric dimethylarginine concentrations are elevated in obese insulin-resistant women and fall with weight loss
    • 10.1210/jc.2005-1441, 16507636
    • McLaughlin T, Stühlinger M, Lamendola C, Abbasi F, Bialek J, Reaven GM, Tsao PS. Plasma asymmetric dimethylarginine concentrations are elevated in obese insulin-resistant women and fall with weight loss. J Clin Endocrinol Metab 2006, 91:1896-1900. 10.1210/jc.2005-1441, 16507636.
    • (2006) J Clin Endocrinol Metab , vol.91 , pp. 1896-1900
    • McLaughlin, T.1    Stühlinger, M.2    Lamendola, C.3    Abbasi, F.4    Bialek, J.5    Reaven, G.M.6    Tsao, P.S.7
  • 17
    • 31844456075 scopus 로고    scopus 로고
    • Elevations of plasma methylarginines in obesity and ageing are related to insulin sensitivity and rates of protein turnover
    • 10.1007/s00125-005-0066-6, 16369774
    • Marliss EB, Chevalier S, Gougeon R, Morais JA, Lamarche M, Adegoke OA, Wu G. Elevations of plasma methylarginines in obesity and ageing are related to insulin sensitivity and rates of protein turnover. Diabetologia 2006, 49:351-359. 10.1007/s00125-005-0066-6, 16369774.
    • (2006) Diabetologia , vol.49 , pp. 351-359
    • Marliss, E.B.1    Chevalier, S.2    Gougeon, R.3    Morais, J.A.4    Lamarche, M.5    Adegoke, O.A.6    Wu, G.7
  • 23
    • 9344254366 scopus 로고    scopus 로고
    • Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine
    • 10.1016/j.metabol.2004.06.026, 15562402
    • Eid HMA, Arnesen H, Hjerkinn EM, Lyberg T, Seljeflot I. Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine. Metabolism 2004, 53:1574-1579. 10.1016/j.metabol.2004.06.026, 15562402.
    • (2004) Metabolism , vol.53 , pp. 1574-1579
    • Eid, H.M.A.1    Arnesen, H.2    Hjerkinn, E.M.3    Lyberg, T.4    Seljeflot, I.5
  • 24
    • 77954773778 scopus 로고    scopus 로고
    • Synergistic effects of asymmetrical dimethyl-L-arginine accumulation and endothelial progenitor cell deficiency on renal function decline during a 2-year follow-up in stable angina
    • 10.1093/ndt/gfp439, 19729464
    • Surdacki A, Marewicz E, Wieczorek-Surdacka E, Rakowski T, Szastak G, Pryjma J, Dudek D, Dubiel JS. Synergistic effects of asymmetrical dimethyl-L-arginine accumulation and endothelial progenitor cell deficiency on renal function decline during a 2-year follow-up in stable angina. Nephrol Dial Transplant 2010, 25:2576-2583. 10.1093/ndt/gfp439, 19729464.
    • (2010) Nephrol Dial Transplant , vol.25 , pp. 2576-2583
    • Surdacki, A.1    Marewicz, E.2    Wieczorek-Surdacka, E.3    Rakowski, T.4    Szastak, G.5    Pryjma, J.6    Dudek, D.7    Dubiel, J.S.8
  • 26
    • 33744958852 scopus 로고    scopus 로고
    • Assessing kidney function - measured and estimated glomerular filtration rate
    • 10.1056/NEJMra054415, 16760447
    • Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function - measured and estimated glomerular filtration rate. N Engl J Med 2006, 354:2473-2483. 10.1056/NEJMra054415, 16760447.
    • (2006) N Engl J Med , vol.354 , pp. 2473-2483
    • Stevens, L.A.1    Coresh, J.2    Greene, T.3    Levey, A.S.4
  • 27
    • 0021813187 scopus 로고
    • Homeostatic model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man
    • 10.1007/BF00280883, 3899825
    • Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostatic model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419. 10.1007/BF00280883, 3899825.
    • (1985) Diabetologia , vol.28 , pp. 412-419
    • Matthews, D.R.1    Hosker, J.P.2    Rudenski, A.S.3    Naylor, B.A.4    Treacher, D.F.5    Turner, R.C.6
  • 30
    • 21344454662 scopus 로고    scopus 로고
    • Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model
    • 10.2337/diabetes.54.7.1914, 15983190
    • Chen H, Sullivan G, Quon MJ. Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model. Diabetes 2005, 54:1914-1925. 10.2337/diabetes.54.7.1914, 15983190.
    • (2005) Diabetes , vol.54 , pp. 1914-1925
    • Chen, H.1    Sullivan, G.2    Quon, M.J.3
  • 31
    • 0030884022 scopus 로고    scopus 로고
    • Endothelial dysfunction: cause of the insulin resistance syndrome
    • Pinkney JH, Stehouwer CD, Coppack SW, Yudkin JS. Endothelial dysfunction: cause of the insulin resistance syndrome. Diabetes 1997, 46(Suppl 2):S9-S13.
    • (1997) Diabetes , vol.46 , Issue.SUPPL. 2
    • Pinkney, J.H.1    Stehouwer, C.D.2    Coppack, S.W.3    Yudkin, J.S.4
  • 32
    • 4444376099 scopus 로고    scopus 로고
    • Cardiovascular disease risk factors predict the development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study
    • 10.2337/diacare.27.9.2234, 15333490, Insulin Resistance Atherosclerosis Study Investigators
    • D'Agostino RB, Hamman RF, Karter AJ, Mykkanen L, Wagenknecht LE, Haffner SM, . Insulin Resistance Atherosclerosis Study Investigators Cardiovascular disease risk factors predict the development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study. Diabetes Care 2004, 27:2234-2240. 10.2337/diacare.27.9.2234, 15333490, Insulin Resistance Atherosclerosis Study Investigators.
    • (2004) Diabetes Care , vol.27 , pp. 2234-2240
    • D'Agostino, R.B.1    Hamman, R.F.2    Karter, A.J.3    Mykkanen, L.4    Wagenknecht, L.E.5    Haffner, S.M.6
  • 33
    • 35148816081 scopus 로고    scopus 로고
    • Risk of type 2 diabetes attributable to C-reactive protein and other risk factors
    • 10.2337/dc07-0348, 17623828
    • Dehghan A, van Hoek M, Sijbrands EJ, Stijnen T, Hofman A, Witteman JC. Risk of type 2 diabetes attributable to C-reactive protein and other risk factors. Diabetes Care 2007, 30:2695-2699. 10.2337/dc07-0348, 17623828.
    • (2007) Diabetes Care , vol.30 , pp. 2695-2699
    • Dehghan, A.1    van Hoek, M.2    Sijbrands, E.J.3    Stijnen, T.4    Hofman, A.5    Witteman, J.C.6
  • 34
    • 0035806626 scopus 로고    scopus 로고
    • Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study
    • 10.1001/jama.286.1.64, 11434828, PRINCE Investigators
    • Albert MA, Danielson E, Rifai N, Ridker PM, . PRINCE Investigators Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA 2001, 286:64-70. 10.1001/jama.286.1.64, 11434828, PRINCE Investigators.
    • (2001) JAMA , vol.286 , pp. 64-70
    • Albert, M.A.1    Danielson, E.2    Rifai, N.3    Ridker, P.M.4
  • 35
    • 12244268005 scopus 로고    scopus 로고
    • Increased levels of asymmetric dimethylarginine in populations at risk for atherosclerotic disease. Effects of pravastatin
    • 10.1016/S0021-9150(02)00206-X, 12535740
    • Eid HM, Eritsland J, Larsen J, Arnesen H, Seljeflot I. Increased levels of asymmetric dimethylarginine in populations at risk for atherosclerotic disease. Effects of pravastatin. Atherosclerosis 2003, 166:279-284. 10.1016/S0021-9150(02)00206-X, 12535740.
    • (2003) Atherosclerosis , vol.166 , pp. 279-284
    • Eid, H.M.1    Eritsland, J.2    Larsen, J.3    Arnesen, H.4    Seljeflot, I.5
  • 36
    • 0036636922 scopus 로고    scopus 로고
    • Angiotensin converting enzyme inhibition and angiotensin II AT1-receptor blockade reduce the levels of asymmetrical NG,NG-dimethylarginine in human essential hypertension
    • 10.1016/S0895-7061(02)02278-1, 12118904
    • Delles C, Schneider MP, John S, Gekle M, Schmieder RE. Angiotensin converting enzyme inhibition and angiotensin II AT1-receptor blockade reduce the levels of asymmetrical NG,NG-dimethylarginine in human essential hypertension. Am J Hypertens 2002, 15:590-593. 10.1016/S0895-7061(02)02278-1, 12118904.
    • (2002) Am J Hypertens , vol.15 , pp. 590-593
    • Delles, C.1    Schneider, M.P.2    John, S.3    Gekle, M.4    Schmieder, R.E.5
  • 37
    • 33847352106 scopus 로고    scopus 로고
    • Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study)
    • Meinitzer A, Seelhorst U, Wellnitz B, Halwachs-Baumann G, Boehm BO, Winkelmann BR, März W. Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study). Clin Chem 2007, 53:273-283.
    • (2007) Clin Chem , vol.53 , pp. 273-283
    • Meinitzer, A.1    Seelhorst, U.2    Wellnitz, B.3    Halwachs-Baumann, G.4    Boehm, B.O.5    Winkelmann, B.R.6    März, W.7
  • 39
    • 42249090741 scopus 로고    scopus 로고
    • Dimethylarginine dimethylaminohydrolase overexpression enhances insulin sensitivity
    • 10.1161/ATVBAHA.108.162073, 3165027, 18239148
    • Sydow K, Mondon CE, Schrader J, Konishi H, Cooke JP. Dimethylarginine dimethylaminohydrolase overexpression enhances insulin sensitivity. Arterioscler Thromb Vasc Biol 2008, 28:692-697. 10.1161/ATVBAHA.108.162073, 3165027, 18239148.
    • (2008) Arterioscler Thromb Vasc Biol , vol.28 , pp. 692-697
    • Sydow, K.1    Mondon, C.E.2    Schrader, J.3    Konishi, H.4    Cooke, J.P.5
  • 40
    • 54949108228 scopus 로고    scopus 로고
    • L-arginine analogs - inactive markers or active agents in atherogenesis ?
    • 10.2174/187152508785909429, 18855643
    • Surdacki A. L-arginine analogs - inactive markers or active agents in atherogenesis ?. Cardiovasc Hematol Agents Med Chem 2008, 6:302-311. 10.2174/187152508785909429, 18855643.
    • (2008) Cardiovasc Hematol Agents Med Chem , vol.6 , pp. 302-311
    • Surdacki, A.1
  • 41
    • 0029119084 scopus 로고
    • Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans
    • 10.1172/JCI118124, 185264, 7635973
    • Baron AD, Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G. Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans. J Clin Invest 1995, 96:786-792. 10.1172/JCI118124, 185264, 7635973.
    • (1995) J Clin Invest , vol.96 , pp. 786-792
    • Baron, A.D.1    Steinberg, H.O.2    Chaker, H.3    Leaming, R.4    Johnson, A.5    Brechtel, G.6
  • 42
    • 0028030813 scopus 로고
    • Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release
    • 10.1172/JCI117433, 295191, 8083357
    • Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 1994, 94:1172-1179. 10.1172/JCI117433, 295191, 8083357.
    • (1994) J Clin Invest , vol.94 , pp. 1172-1179
    • Steinberg, H.O.1    Brechtel, G.2    Johnson, A.3    Fineberg, N.4    Baron, A.D.5
  • 43
    • 0028113927 scopus 로고
    • Nitric oxide release accounts for insulin's vascular effects in humans
    • 10.1172/JCI117621, 330085, 7989610
    • Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P. Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest 1994, 94:2511-2515. 10.1172/JCI117621, 330085, 7989610.
    • (1994) J Clin Invest , vol.94 , pp. 2511-2515
    • Scherrer, U.1    Randin, D.2    Vollenweider, P.3    Vollenweider, L.4    Nicod, P.5
  • 44
    • 0028046502 scopus 로고
    • Nitric oxide in skeletal muscle
    • 10.1038/372546a0, 7527495
    • Kobzik L, Reid MB, Bredt DS, Stamler JS. Nitric oxide in skeletal muscle. Nature 1994, 372:546-548. 10.1038/372546a0, 7527495.
    • (1994) Nature , vol.372 , pp. 546-548
    • Kobzik, L.1    Reid, M.B.2    Bredt, D.S.3    Stamler, J.S.4
  • 45
    • 0013054309 scopus 로고    scopus 로고
    • Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance
    • 10.2337/diabetes.49.5.684, 10905473
    • Shankar RR, Wu Y, Shen HQ, Zhu JS, Baron AD. Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance. Diabetes 2000, 49:684-687. 10.2337/diabetes.49.5.684, 10905473.
    • (2000) Diabetes , vol.49 , pp. 684-687
    • Shankar, R.R.1    Wu, Y.2    Shen, H.Q.3    Zhu, J.S.4    Baron, A.D.5
  • 46
    • 79651475617 scopus 로고    scopus 로고
    • The association of dimethylarginine dimethylaminohydrolase 1 gene polymorphism with type 2 diabetes: a cohort study
    • 10.1186/1475-2840-10-16, 3050685, 21303562
    • Lu TM, Lin SJ, Lin MW, Hsu CP, Chung MY. The association of dimethylarginine dimethylaminohydrolase 1 gene polymorphism with type 2 diabetes: a cohort study. Cardiovasc Diabetol 2011, 10:16. 10.1186/1475-2840-10-16, 3050685, 21303562.
    • (2011) Cardiovasc Diabetol , vol.10 , pp. 16
    • Lu, T.M.1    Lin, S.J.2    Lin, M.W.3    Hsu, C.P.4    Chung, M.Y.5
  • 47
    • 38449122045 scopus 로고    scopus 로고
    • Rosiglitazone improves endothelial function and inflammation but not asymmetric dimethylarginine or oxidative stress in patients with type 2 diabetes mellitus
    • 10.1177/1358863X07084200, 18048467
    • Kelly AS, Thelen AM, Kaiser DR, Gonzalez-Campoy JM, Bank AJ. Rosiglitazone improves endothelial function and inflammation but not asymmetric dimethylarginine or oxidative stress in patients with type 2 diabetes mellitus. Vasc Med 2007, 12:311-318. 10.1177/1358863X07084200, 18048467.
    • (2007) Vasc Med , vol.12 , pp. 311-318
    • Kelly, A.S.1    Thelen, A.M.2    Kaiser, D.R.3    Gonzalez-Campoy, J.M.4    Bank, A.J.5
  • 48
    • 0037143637 scopus 로고    scopus 로고
    • Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase
    • 10.1161/01.CIR.0000027109.14149.67, 12186805
    • Lin KY, Ito A, Asagami T, Tsao PS, Adimoolam S, Kimoto M, Tsuji H, Reaven GM, Cooke JP. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation 2002, 106:987-992. 10.1161/01.CIR.0000027109.14149.67, 12186805.
    • (2002) Circulation , vol.106 , pp. 987-992
    • Lin, K.Y.1    Ito, A.2    Asagami, T.3    Tsao, P.S.4    Adimoolam, S.5    Kimoto, M.6    Tsuji, H.7    Reaven, G.M.8    Cooke, J.P.9
  • 49
    • 3442882851 scopus 로고    scopus 로고
    • Cell signalling-mediating insulin increase of mRNA expression for cationic amino acid transporters-1 and -2 and membrane hyperpolarization in human umbilical vein endothelial cells
    • Gonzalez M, Flores C, Pearson JD, Casanello P, Sobrevia L. Cell signalling-mediating insulin increase of mRNA expression for cationic amino acid transporters-1 and -2 and membrane hyperpolarization in human umbilical vein endothelial cells. Pflugers Arch 2004, 448:383-394.
    • (2004) Pflugers Arch , vol.448 , pp. 383-394
    • Gonzalez, M.1    Flores, C.2    Pearson, J.D.3    Casanello, P.4    Sobrevia, L.5
  • 50
    • 70350048649 scopus 로고    scopus 로고
    • Cellular ADMA: regulation and action
    • 10.1016/j.phrs.2009.08.002, 2767414, 19682580
    • Teerlink T, Luo Z, Palm F, Wilcox CS. Cellular ADMA: regulation and action. Pharmacol Res 2009, 60:448-460. 10.1016/j.phrs.2009.08.002, 2767414, 19682580.
    • (2009) Pharmacol Res , vol.60 , pp. 448-460
    • Teerlink, T.1    Luo, Z.2    Palm, F.3    Wilcox, C.S.4
  • 51
    • 33947200791 scopus 로고    scopus 로고
    • Decreased levels of asymmetric dimethylarginine during acute hyperinsulinemia
    • 10.1016/j.metabol.2006.11.003, 17379002
    • Eid HM, Reims H, Arnesen H, Kjeldsen SE, Lyberg T, Seljeflot I. Decreased levels of asymmetric dimethylarginine during acute hyperinsulinemia. Metabolism 2007, 56:464-469. 10.1016/j.metabol.2006.11.003, 17379002.
    • (2007) Metabolism , vol.56 , pp. 464-469
    • Eid, H.M.1    Reims, H.2    Arnesen, H.3    Kjeldsen, S.E.4    Lyberg, T.5    Seljeflot, I.6
  • 53
    • 80054883738 scopus 로고    scopus 로고
    • Changes in the arginine methylation of organ proteins during the development of diabetes mellitus
    • 10.1016/j.diabres.2011.07.005, 21855157
    • Lee JH, Park GH, Lee YK, Park JH. Changes in the arginine methylation of organ proteins during the development of diabetes mellitus. Diabetes Res Clin Pract 2011, 94:111-118. 10.1016/j.diabres.2011.07.005, 21855157.
    • (2011) Diabetes Res Clin Pract , vol.94 , pp. 111-118
    • Lee, J.H.1    Park, G.H.2    Lee, Y.K.3    Park, J.H.4
  • 54
    • 0041666333 scopus 로고    scopus 로고
    • Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?
    • The DECODE, 10.2337/diacare.26.3.688, 12610023, Study Group on behalf of the European Diabetes Epidemiology Group
    • The DECODE, . Study Group on behalf of the European Diabetes Epidemiology Group Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?. Diabetes Care 2003, 26:688-696. 10.2337/diacare.26.3.688, 12610023, Study Group on behalf of the European Diabetes Epidemiology Group.
    • (2003) Diabetes Care , vol.26 , pp. 688-696
  • 55
    • 33846669408 scopus 로고    scopus 로고
    • High risk of cardiovascular mortality in individuals with impaired fasting glucose is explained by conversion to diabetes: the Hoorn study
    • 10.2337/dc06-1238, 17259503
    • Rijkelijkhuizen JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD, Dekker JM. High risk of cardiovascular mortality in individuals with impaired fasting glucose is explained by conversion to diabetes: the Hoorn study. Diabetes Care 2007, 30:332-336. 10.2337/dc06-1238, 17259503.
    • (2007) Diabetes Care , vol.30 , pp. 332-336
    • Rijkelijkhuizen, J.M.1    Nijpels, G.2    Heine, R.J.3    Bouter, L.M.4    Stehouwer, C.D.5    Dekker, J.M.6
  • 56
    • 33645034037 scopus 로고    scopus 로고
    • Coronary endothelial dysfunction is associated with erectile dysfunction and elevated asymmetric dimethylarginine in patients with early atherosclerosis
    • 10.1093/eurheartj/ehi749, 16434411
    • Elesber AA, Solomon H, Lennon RJ, Mathew V, Prasad A, Pumper G, Nelson RE, McConnell JP, Lerman LO, Lerman A. Coronary endothelial dysfunction is associated with erectile dysfunction and elevated asymmetric dimethylarginine in patients with early atherosclerosis. Eur Heart J 2006, 27:824-831. 10.1093/eurheartj/ehi749, 16434411.
    • (2006) Eur Heart J , vol.27 , pp. 824-831
    • Elesber, A.A.1    Solomon, H.2    Lennon, R.J.3    Mathew, V.4    Prasad, A.5    Pumper, G.6    Nelson, R.E.7    McConnell, J.P.8    Lerman, L.O.9    Lerman, A.10
  • 58
    • 84877624391 scopus 로고    scopus 로고
    • Comparison of plasma viscosity as a marker of endothelial dysfunction with nitric oxide and asymmetric dimethylarginine in subjects with dyslipidemia
    • Epub ahead of print
    • Ercan M, Firtina S, Konukoglu D. Comparison of plasma viscosity as a marker of endothelial dysfunction with nitric oxide and asymmetric dimethylarginine in subjects with dyslipidemia. Clin Hemorheol Microcirc 2013, Epub ahead of print.
    • (2013) Clin Hemorheol Microcirc
    • Ercan, M.1    Firtina, S.2    Konukoglu, D.3
  • 59
    • 79954933210 scopus 로고    scopus 로고
    • Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and diabetes: a meta-analysis of placebo-controlled clinical trials
    • 10.1038/ajh.2011.8, 21331058
    • Tocci G, Paneni F, Palano F, Sciarretta S, Ferrucci A, Kurtz T, Mancia G, Volpe M. Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and diabetes: a meta-analysis of placebo-controlled clinical trials. Am J Hypertens 2011, 24:582-590. 10.1038/ajh.2011.8, 21331058.
    • (2011) Am J Hypertens , vol.24 , pp. 582-590
    • Tocci, G.1    Paneni, F.2    Palano, F.3    Sciarretta, S.4    Ferrucci, A.5    Kurtz, T.6    Mancia, G.7    Volpe, M.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.